Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Rothman

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Health Services Research and Managerial Epidemiology|July 14, 2022
Impact of the COVID-19 Pandemic on Healthcare Resource Utilization in Individuals with Major Depressive DisorderJoshua N Liberman, Sandipan Bhattacharjee, Pinyao Rui, et al.
Acta Neuropsychiatrica|November 19, 2024
A randomised study and an extension study of brexpiprazole in patients with borderline personality disorderBrian Rothman, Claudette Brewer, Denise Chang, et al.
Journal of the American Medical Informatics Association : JAMIA|June 11, 2013
Automated identification of drug and food allergies entered using non-standard terminologyRichard H Epstein, Paul St Jacques, Michael Stockin, et al.
Journal of Clinical Psychopharmacology|January 2, 2013
Assessing the sources of unreliability (rater, subject, time-point) in a failed clinical trial using items of the Positive and Negative Syndrome Scale (PANSS)Anzalee Khan, William Christian Yavorsky, Stacy Liechti, et al.
BMC Psychology|January 8, 2015
A rasch model to test the cross-cultural validity in the positive and negative syndrome scale (PANSS) across six geo-cultural groupsAnzalee Khan, Christian Yavorsky, Stacy Liechti, et al.
BMJ Evidence-Based Medicine|July 19, 2019
Are CAR-T therapies living up to their hype? A study using real-world data in two cohorts to determine how well they are actually working in practice compared with bone marrow transplantsDuane Schulthess, Daniel Gassull, Amr Makady, et al.
JMIR Research Protocols|August 20, 2024
Evaluating the Efficacy of a Digital Therapeutic (CT-152) as an Adjunct to Antidepressant Treatment in Adults With Major Depressive Disorder: Protocol for the MIRAI Remote StudyBrian Rothman, Mary Slomkowski, Austin Speier, et al.
Journal of Affective Disorders|May 16, 2025
A digital therapeutic (CT-152) as adjunct to antidepressant medication: A phase 3 randomized controlled trial (the Mirai study)Brian Rothman, Mary Slomkowski, Austin Speier, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Health Services Research and Managerial Epidemiology|July 14, 2022
Impact of the COVID-19 Pandemic on Healthcare Resource Utilization in Individuals with Major Depressive DisorderJoshua N Liberman, Sandipan Bhattacharjee, Pinyao Rui, et al.
Acta Neuropsychiatrica|November 19, 2024
A randomised study and an extension study of brexpiprazole in patients with borderline personality disorderBrian Rothman, Claudette Brewer, Denise Chang, et al.
Journal of the American Medical Informatics Association : JAMIA|June 11, 2013
Automated identification of drug and food allergies entered using non-standard terminologyRichard H Epstein, Paul St Jacques, Michael Stockin, et al.
Journal of Clinical Psychopharmacology|January 2, 2013
Assessing the sources of unreliability (rater, subject, time-point) in a failed clinical trial using items of the Positive and Negative Syndrome Scale (PANSS)Anzalee Khan, William Christian Yavorsky, Stacy Liechti, et al.
BMC Psychology|January 8, 2015
A rasch model to test the cross-cultural validity in the positive and negative syndrome scale (PANSS) across six geo-cultural groupsAnzalee Khan, Christian Yavorsky, Stacy Liechti, et al.
BMJ Evidence-Based Medicine|July 19, 2019
Are CAR-T therapies living up to their hype? A study using real-world data in two cohorts to determine how well they are actually working in practice compared with bone marrow transplantsDuane Schulthess, Daniel Gassull, Amr Makady, et al.
JMIR Research Protocols|August 20, 2024
Evaluating the Efficacy of a Digital Therapeutic (CT-152) as an Adjunct to Antidepressant Treatment in Adults With Major Depressive Disorder: Protocol for the MIRAI Remote StudyBrian Rothman, Mary Slomkowski, Austin Speier, et al.
Journal of Affective Disorders|May 16, 2025
A digital therapeutic (CT-152) as adjunct to antidepressant medication: A phase 3 randomized controlled trial (the Mirai study)Brian Rothman, Mary Slomkowski, Austin Speier, et al.
Pageof 2